BioTrace Medical, founded by Aravind Swaminathan and Ellis Garai in 2013, is a medical device company based in San Mateo, California. The company’s core mission is to reinvent temporary pacing to enhance patient outcomes and lower hospital costs. BioTrace Medical specializes in the production of innovative temporary pacing devices, notably the Tempo® Temporary Pacing Lead, which provides secure and stable pacing, reducing complications and enabling quicker patient mobility post-procedures such as TAVR, TMVR, and cardiac surgeries.

Notable affiliates include Merit Medical, which acquired BioTrace Medical, enhancing the company's reach and impact in the medical device market. Key achievements include the development of the Tempo® Lead, which boasts zero perforations, effusions, or arrhythmias, setting a new standard in temporary pacing. BioTrace Medical has significantly impacted patient care by improving procedural outcomes and reducing hospital stays and associated costs.